4//SEC Filing
CoLucid Pharmaceuticals, Inc. 4
Accession 0000911916-17-000076
CIK 0001348649operating
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 12:20 PM ET
Size
18.9 KB
Accession
0000911916-17-000076
Insider Transaction Report
Form 4
Marengere Luc
Director10% Owner
Transactions
- Disposition from Tender
Common Stock
2017-03-01$46.50/sh−1,545,386$71,860,449→ 0 total(indirect: By TVM Life Science Ventures VII L.P.) - Disposition to Issuer
Stock Option (Right to Buy)
2017-03-01$36.50/sh−5,954$217,321→ 0 totalExercise: $10.00Exp: 2025-05-05→ Common Stock (5,954 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2017-03-01$40.26/sh−8,897$358,193→ 0 totalExercise: $6.24Exp: 2026-05-10→ Common Stock (8,897 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2017-03-01$38.00/sh−1,449$55,062→ 0 totalExercise: $8.50Exp: 2026-01-04→ Common Stock (1,449 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2017-03-01$36.88/sh−2,371$87,442→ 0 totalExercise: $9.62Exp: 2026-07-01→ Common Stock (2,371 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2017-03-01$10.30/sh−658$6,777→ 0 totalExercise: $36.20Exp: 2027-01-03→ Common Stock (658 underlying)
TVM Life Science Ventures VII L.P.
10% Owner
Transactions
- Disposition from Tender
Common Stock
2017-03-01$46.50/sh−1,545,386$71,860,449→ 0 total(indirect: By TVM Life Science Ventures VII L.P.) - Disposition to Issuer
Stock Option (Right to Buy)
2017-03-01$36.88/sh−2,371$87,442→ 0 totalExercise: $9.62Exp: 2026-07-01→ Common Stock (2,371 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2017-03-01$10.30/sh−658$6,777→ 0 totalExercise: $36.20Exp: 2027-01-03→ Common Stock (658 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2017-03-01$36.50/sh−5,954$217,321→ 0 totalExercise: $10.00Exp: 2025-05-05→ Common Stock (5,954 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2017-03-01$38.00/sh−1,449$55,062→ 0 totalExercise: $8.50Exp: 2026-01-04→ Common Stock (1,449 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2017-03-01$40.26/sh−8,897$358,193→ 0 totalExercise: $6.24Exp: 2026-05-10→ Common Stock (8,897 underlying)
Footnotes (4)
- [F1]Pursuant to the terms of the Agreement and Plan of Merger, dated January 17, 2017 (the "Merger Agreement"), by and among CoLucid Pharmaceuticals, Inc. (the "Issuer"), Eli Lilly and Company ("Lilly") and ProCar Acquisition Corporation, a wholly-owned subsidiary of Lilly, these shares were tendered pursuant to the Merger Agreement in exchange for a cash payment of $46.50 per share in cash, without interest.
- [F2]Represents securities held directly by TVM Life Science Ventures VII L.P. TVM Life Science Ventures VII (GP) Ltd. is the general partner of TVM Life Science Ventures VII L.P. The reporting person is a managing partner of the investment team of TVM Life Science Venture Capital, which has voting and investment power with respect to these shares. The reporting person may be deemed to be an indirect beneficial owner of the reported securities. The reporting person disclaims any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F3]Pursuant to the terms of the Merger Agreement, these options, which were fully vested, were cancelled in exchange for a cash payment of $46.50 less the per share exercise price multiplied by the number of unexercised options, without interest.
- [F4]Pursuant to the terms of the Merger Agreement, these options, which provided for full vesting immediately prior to the start of the Issuer's first annual meeting of stockholders following the date of grant, were cancelled in exchange for a cash payment of $46.50 less the per share exercise price multiplied by the number of unexercised options, without interest.
Documents
Issuer
CoLucid Pharmaceuticals, Inc.
CIK 0001348649
Entity typeoperating
Related Parties
1- filerCIK 0001348649
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 12:20 PM ET
- Size
- 18.9 KB